Herpes Zoster Infection
Although accreditation for this CE/CME activity has expired, and the posttest is no longer available, you can still read the full article.
Expires August 31, 2014
–
Herpes zoster (HZ) infection, commonly called shingles, represents a reactivation of the chickenpox virus. Persons older than 50 and those with compromised immune systems are at greatest risk. Most cases resolve spontaneously, but about one-third of patients develop postherpetic neuralgia or other complications, and 1% to 4% require hospitalization. Treatment involves antiviral medications and
pain management. Vaccination against HZ, which is recommended for adults 60 and older,
incurs benefits and risks that the clinician must be prepared to explain to eligible patients.
CONCLUSION
Herpes zoster remains a common disease in the US, despite the availability of an effective vaccine. While most cases of shingles resolve spontaneously, life-threatening and permanent complications can occur. Treatment may shorten the length of illness and prevent these complications. Primary care providers should recommend routine vaccination against HZ for their immunocompetent patients 60 or older.
